Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

8.07
-0.4950-5.78%
Volume:2.11M
Turnover:17.05M
Market Cap:797.21M
PE:-4.64
High:8.64
Open:8.57
Low:7.61
Close:8.56
52wk High:18.90
52wk Low:6.66
Shares:98.85M
Float Shares:55.27M
Volume Ratio:0.93
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7400
EPS(LYR):-1.7400
ROE:-92.33%
ROA:-33.04%
PB:6.98
PE(LYR):-4.64

Loading ...

Mar 09, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 09, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2026

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Sep 29, 2025

Major Issues Report

Form 8-K - Current report
Aug 28, 2025

Major Issues Report

Form 8-K - Current report
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 26, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities